Feasibility of androgen-deprivation and radiation therapy with docetaxel for localized high-risk prostate cancer

Transl Androl Urol. 2024 Jul 31;13(7):1324-1326. doi: 10.21037/tau-23-669. Epub 2024 Jun 27.

Authors

Hiroaki Iwamoto¹, Kouji Izumi¹, Atsushi Mizokami¹

Affiliation

¹ Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.

No abstract available

Keywords: CCL2; Prostate cancer (PC); androgen deprivation; docetaxel; localized high risk prostate cancer.

Publication types

Editorial
Comment